Cargando…
Third generation drug eluting stent (DES) with biodegradable polymer in diabetic patients: 5 years follow-up
OBJECTIVE: To report the long-term safety and efficacy data of a third generation drug eluting stent (DES) with biodegradable polymer in the complex patient population of diabetes mellitus after a follow-up period of 5 years. BACKGROUND: After percutaneous coronary intervention patients with diabete...
Autores principales: | Wiemer, Marcus, Stoikovic, Sinisa, Samol, Alexander, Dimitriadis, Zisis, Ruiz-Nodar, Juan M., Birkemeyer, Ralf, Monsegu, Jacques, Finet, Gérard, Hildick-Smith, David, Tresukosol, Damras, Novo, Enrique Garcia, Koolen, Jacques J., Barbato, Emanuele, Danzi, Gian Battista |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5301341/ https://www.ncbi.nlm.nih.gov/pubmed/28183306 http://dx.doi.org/10.1186/s12933-017-0500-3 |
Ejemplares similares
-
Erratum to: Third generation drug eluting stent (DES) with biodegradable polymer in diabetic patients: 5 years follow-up
por: Wiemer, Marcus, et al.
Publicado: (2017) -
Thin Strut CoCr Biodegradable Polymer Biolimus A9-Eluting Stents versus Thicker Strut Stainless Steel Biodegradable Polymer Biolimus A9-Eluting Stents: Two-Year Clinical Outcomes
por: Menown, Ian B. A., et al.
Publicado: (2021) -
Drug-eluting stents with biodegradable polymer for the treatment of patients with diabetes mellitus: clinical outcome at 2 years in a large population of patients
por: Wiemer, Marcus, et al.
Publicado: (2015) -
The Ultimaster Biodegradable-Polymer Sirolimus-Eluting Stent: An Updated Review of Clinical Evidence
por: Chisari, Alberto, et al.
Publicado: (2016) -
First clinical evidence characterizing safety and efficacy of the new CoCr Biolimus-A9 eluting stent: The Biomatrix Alpha™ registry
por: Menown, Ian B.A., et al.
Publicado: (2020)